Allison Kempe1,2, Alison W Saville3, Christina Albertin4, Gregory Zimet5, Abigail Breck4, Laura Helmkamp3, Sitaram Vangala6, L Miriam Dickinson3, Cindy Rand7, Sharon Humiston8, Peter G Szilagyi4. 1. Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado; Allison.Kempe@childrenscolorado.org. 2. Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado. 3. Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado and Children's Hospital Colorado, Aurora, Colorado. 4. Department of Pediatrics, University of California at Los Angeles Mattel Children's Hospital and University of California at Los Angeles, Los Angeles, California. 5. Department of Pediatrics, School of Medicine, Indiana University, Indianapolis, Indiana. 6. Department of Medicine Statistics Core, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California. 7. Department of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, New York; and. 8. Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
Abstract
BACKGROUND AND OBJECTIVES: The World Health Organization has designated vaccine hesitancy as 1 of the 10 leading threats to global health, yet there is limited current national data on prevalence of hesitancy among US parents. Among a nationally representative sample of US parents, we aimed to (1) assess and compare prevalence of hesitancy and factors driving hesitancy for routine childhood and influenza vaccination and (2) examine associations between sociodemographic characteristics and hesitancy for routine childhood or influenza vaccination. METHODS: In February 2019, we surveyed families with children using the largest online panel generating representative US samples. After weighting, we assessed hesitancy using a modified 5-point Vaccine Hesitancy Scale and labeled parents as hesitant if they scored >3. RESULTS: A total of 2176 of 4445 parents sampled completed the survey (response rate 49%). Hesitancy prevalence was 6.1% for routine childhood and 25.8% for influenza vaccines; 12% strongly and 27% somewhat agreed they had concerns about serious side effects of both routine childhood and influenza vaccines. A total of 70% strongly agreed that routine childhood vaccines are effective versus 26% for influenza vaccine (P < .001). In multivariable models, an educational level lower than a bachelor's degree and household income <400% of the federal poverty level predicted hesitancy about both routine childhood and influenza vaccines. CONCLUSIONS: Almost 1 in 15 US parents are hesitant about routine childhood vaccines, whereas >1 in 4 are hesitant about influenza vaccine. Furthermore, 1 in 8 parents are concerned about vaccine safety for both routine childhood and influenza vaccines, and only 1 in 4 believe influenza vaccine is effective. Vaccine hesitancy, particularly for influenza vaccine, is prevalent in the United States.
BACKGROUND AND OBJECTIVES: The World Health Organization has designated vaccine hesitancy as 1 of the 10 leading threats to global health, yet there is limited current national data on prevalence of hesitancy among US parents. Among a nationally representative sample of US parents, we aimed to (1) assess and compare prevalence of hesitancy and factors driving hesitancy for routine childhood and influenza vaccination and (2) examine associations between sociodemographic characteristics and hesitancy for routine childhood or influenza vaccination. METHODS: In February 2019, we surveyed families with children using the largest online panel generating representative US samples. After weighting, we assessed hesitancy using a modified 5-point Vaccine Hesitancy Scale and labeled parents as hesitant if they scored >3. RESULTS: A total of 2176 of 4445 parents sampled completed the survey (response rate 49%). Hesitancy prevalence was 6.1% for routine childhood and 25.8% for influenza vaccines; 12% strongly and 27% somewhat agreed they had concerns about serious side effects of both routine childhood and influenza vaccines. A total of 70% strongly agreed that routine childhood vaccines are effective versus 26% for influenza vaccine (P < .001). In multivariable models, an educational level lower than a bachelor's degree and household income <400% of the federal poverty level predicted hesitancy about both routine childhood and influenza vaccines. CONCLUSIONS: Almost 1 in 15 US parents are hesitant about routine childhood vaccines, whereas >1 in 4 are hesitant about influenza vaccine. Furthermore, 1 in 8 parents are concerned about vaccine safety for both routine childhood and influenza vaccines, and only 1 in 4 believe influenza vaccine is effective. Vaccine hesitancy, particularly for influenza vaccine, is prevalent in the United States.
Authors: Douglas J Opel; John Heritage; James A Taylor; Rita Mangione-Smith; Halle Showalter Salas; Victoria Devere; Chuan Zhou; Jeffrey D Robinson Journal: Pediatrics Date: 2013-11-04 Impact factor: 7.124
Authors: Rachel M Cunningham; Charles G Minard; Danielle Guffey; Laurie S Swaim; Douglas J Opel; Julie A Boom Journal: Acad Pediatr Date: 2017-08-04 Impact factor: 3.107
Authors: Kathryn E Flynn; Dane Whicker; Li Lin; Rachel Cusatis; Alan Nyitray; Kevin P Weinfurt Journal: J Gen Intern Med Date: 2019-08-26 Impact factor: 5.128
Authors: Edward A Belongia; Burney A Kieke; James G Donahue; Robert T Greenlee; Amanda Balish; Angie Foust; Stephen Lindstrom; David K Shay Journal: J Infect Dis Date: 2009-01-15 Impact factor: 5.226
Authors: Elizabeth Karras; Cara M Stokes; Sara C Warfield; Shannon K Barth; Robert M Bossarte Journal: Soc Sci Med Date: 2019-08-03 Impact factor: 4.634
Authors: Tammy A Santibanez; Kimberly H Nguyen; Stacie M Greby; Allison Fisher; Paul Scanlon; Achal Bhatt; Anup Srivastav; James A Singleton Journal: Pediatrics Date: 2020-11-09 Impact factor: 7.124
Authors: Kimberly H Nguyen; Anup Srivastav; Megan C Lindley; Allison Fisher; David Kim; Stacie M Greby; James Lee; James A Singleton Journal: Am J Prev Med Date: 2021-12-08 Impact factor: 5.043
Authors: Jason M Glanz; Nicole M Wagner; Komal J Narwaney; Jennifer Pyrzanowski; Bethany M Kwan; Carter Sevick; Kenneth Resnicow; Amanda F Dempsey Journal: Pediatrics Date: 2020-10-12 Impact factor: 7.124
Authors: Rachel M Cunningham; Danielle Guffey; Charles G Minard; Douglas J Opel; Julie A Boom Journal: Hum Vaccin Immunother Date: 2021-01-26 Impact factor: 3.452
Authors: Sarah Bauerle Bass; Maureen Wilson-Genderson; Dina T Garcia; Aderonke A Akinkugbe; Maghboeba Mosavel Journal: Front Public Health Date: 2021-04-29
Authors: Carlos Lerner; Christina Albertin; Alejandra Casillas; O Kenrik Duru; Michael K Ong; Sitaram Vangala; Sharon Humiston; Sharon Evans; Michael Sloyan; Craig R Fox; Jonathan E Bogard; Sarah Friedman; Peter G Szilagyi Journal: Pediatrics Date: 2021-08 Impact factor: 7.124
Authors: Matthew F Daley; Liza M Reifler; Jo Ann Shoup; Komal J Narwaney; Elyse O Kharbanda; Holly C Groom; Michael L Jackson; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Joshua T B Williams; Eric S Weintraub; Michael M McNeil; Jason M Glanz Journal: Am J Prev Med Date: 2021-04-30 Impact factor: 5.043